Joseph B Sempa

Datos Biográficos

ID7787358
NOMBREJoseph B Sempa
NOMBRESJoseph B
APELLIDOSempa
FIRMASEMPA J B
AFILIACIONESUniversity of the Free State
ORCID0000-0003-1062-0417
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2012
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Establishment of antiretroviral pediatric registry

    Open AccessBukola R Omotoso, Bridget Omotoso et al.ARTICLEFrontiers in Public Health2025

    Globally, there are approximately 1·5 million children (0–14 years old) living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), of which 90% are in sub-Saharan Africa. South Africa has the most extensive pediatric HIV care and treatment program. Statistical data from 2023 demonstrated that 152,984 South African children (<15 years) were living with HIV. Despite the remarkable progress toward achieving the UNAIDS 95…

  • Aligning the principles and practice of research integrity and research fairness in global health

    Open AccessJoseph B Sempa, Rutuja Patil et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: In the past decade, global health research has seen a growing emphasis on research integrity and fairness. The concept of research integrity emerged in response to the reproducibility crisis in science during the late 2000s. Research fairness initiatives aim to enhance ownership and inclusivity in research involving partners with varying powers, decision-making roles and resource capacities, ultimately prioritising local health rese…

  • Knowledge and perceptions of brucellosis in the pastoral communities adjacent to Lake Mburo National Park, Uganda

    Open AccessCatherine Kansiime, Anthony Mugisha et al.ARTICLEBMC Public Health2014

    There was moderate overall knowledge of human and animal brucellosis among the participants. Majority of the participants believed that close proximity to wildlife contributes to the presence of the disease in the area. There is a need for collaboration between the public health, veterinary and wildlife sectors to provide health education on brucellosis for better management of the disease in the communities

  • Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda

    Open AccessJoseph B Sempa, Joseph Sempa et al.ARTICLEBMC Public Health2012

    In HIV-positive patients presenting with CD4 count between 250-350 cells/μl, immediate initiation of cART is a highly cost-effective strategy using the recommended one-time per capita GDP threshold of $490 reported for Uganda. This would constitute an efficient use of scarce health care funds